Therapeutic Potential of Nanomedicine in Management of Alzheimer’s Disease and Glioma
International Journal of Nanomedicine · 2023
DOI: 10.2147/ijn.s405454 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2023. Verfasst von Firoz Anwar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia. Hauptthemen laut MEDLINE: Alzheimer Disease, Glioblastoma, Glioma, Nanoparticles. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 260 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Demenz
Abstract (Originalsprache)
Neoplasm (Glioblastoma) and Alzheimer's disease (AD) comprise two of the most chronic psychological ailments. Glioblastoma is one of the aggressive and prevalent malignant diseases characterized by rapid growth and invasion resulting from cell migration and degradation of extracellular matrix. While the latter is characterized by extracellular plaques of amyloid and intracellular tangles of tau proteins. Both possess a high degree of resistance to treatment owing to the restricted transport of corresponding drugs to the brain protected by the blood-brain barrier (BBB). Development of optimized therapies using advanced technologies is a great need of today. One such approach is the designing of nanoparticles (NPs) to facilitate the drug delivery at the target site. The present article elaborates the advances in nanomedicines in treatment of both AD as well as Gliomas. The intention of this review is to provide an overview of different types of NPs with their physical properties emphasizing their importance in traversing the BBB and hitting the target site. Further, we discuss the therapeutic applications of these NPs along with their specific targets. Multiple overlapping factors with a common pathway in development of AD and Glioblastoma are discussed in details that will assist the readers in developing the conceptual approach to target the NP for an aging population in the given circumstances with limitations of currently designed NPs, and the challenges to meet and the future perspectives.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.
- Department of Biomedical Sciences, College of Medicine, Gulf Medical University, Ajman, United Arab Emirates.
- Department of Chemistry, College of Sciences & Arts, Rabigh King Abdulaziz University, Jeddah, Saudi Arabia.
- Natural Product Discovery Laboratory, Department of Pharmaceutical Sciences, Shalom Institute of Health and Allied Sciences, SHUATS, Prayagraj, India.
ORCID-Profile: Fahad A Al-Abbasi, Ryan Adnan Sheikh, Vikas Kumar
Zitieren
APA
Anwar, F., Al-Abbasi, F. A., Naqvi, S., Sheikh, R. A., Alhayyani, S., Asseri, A. H., Asar, T. O., & Kumar, V. (2023). Therapeutic Potential of Nanomedicine in Management of Alzheimer’s Disease and Glioma. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s405454
Vancouver
Anwar F, Al-Abbasi FA, Naqvi S, Sheikh RA, Alhayyani S, Asseri AH, et al. Therapeutic Potential of Nanomedicine in Management of Alzheimer’s Disease and Glioma. International Journal of Nanomedicine. 2023. doi:10.2147/ijn.s405454
BibTeX
@article{Anwar2023,
author = {Anwar, Firoz and Al-Abbasi, Fahad A and Naqvi, Salma and Sheikh, Ryan Adnan and Alhayyani, Sultan and Asseri, Amer H and Asar, Turky Omar and Kumar, Vikas},
title = {Therapeutic Potential of Nanomedicine in Management of Alzheimer’s Disease and Glioma},
journal = {International Journal of Nanomedicine},
year = {2023},
doi = {10.2147/ijn.s405454}
}
EUVIMED